Some good news in our race for a COVID-19 vaccine.
Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.
Some good news in our race for a COVID-19 vaccine.
Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.
Global coronavirus cases rose by more than 400,000 for the first time late on Friday, a record one-day increase as much of Europe..